{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-001046","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2023-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.643452+00:00","generated_at":"2026-06-19T22:19:22.053144+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Azenta Q1 revenue $178M (+28% YoY); GAAP EPS ($0.15) vs $0.04 prior year; guides Q2 revenue $156-171M","bullets":["Revenue $178M, up 28% YoY; organic growth ex-COVID of 7%.","GAAP diluted EPS from continuing ops ($0.15) vs $0.04 prior year; non-GAAP EPS $0.12 flat YoY.","Life Sciences Products revenue $90M (+80% YoY) driven by B Medical acquisition; Services $89M (-1%).","Q2 FY23 guidance: revenue $156-171M, non-GAAP EPS ($0.04)-$0.04, GAAP EPS ($0.24)-($0.16).","Initiated cost cuts targeting 2 points margin improvement in 2H FY23; completed Ziath acquisition on Feb 2, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-001046","json":"https://secwatch.observer/filing/0001558370-23-001046.json","markdown":"https://secwatch.observer/filing/0001558370-23-001046.md","text":"https://secwatch.observer/filing/0001558370-23-001046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000155837023001046/0001558370-23-001046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000155837023001046/azta-20230208x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T22:19:22.053144+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1838aada29615d88b58d1083d5b1175c90ab1e12","claim":"Azenta, Inc. reported first quarter ended December 31, 2022 results: revenue $178 million, EPS $ (0.15). Guidance initiated.","evidence_excerpt":"● Reported Q1’23 Revenue of $178 Million and Growth of 28% Year-Over-Year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/933974/000155837023001046/0001558370-23-001046-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended December 31, 2022"},{"label":"Revenue","value":"$178 million"},{"label":"EPS","value":"$ (0.15)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}